Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug

Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug

Source: 
Stat
snippet: 

Former health secretary Donna Shalala called for a federal investigation into the Food and Drug Administration’s polarizing approval of a Biogen treatment for Alzheimer’s disease, citing STAT’s revelation Tuesday that regulators were far more closely aligned with the company than previously disclosed.